Financebotresearch desk研究台

MA › analyze

MA · Analyze

ACCUMULATE Fintech

Sleeve-vacancy nomination — 🏛 Evergreen Compounders. Not currently tracked. This nomination recurred in the 8/27 watchlist scan (as a rotation question against Visa) and again in the current scan; this is the first full standalone /analyze on the name. Price 2026-09-10: $565.37 (MktCap $495.27B, EV $508.30B) — 6.0% below the 52-week/all-time high ($601.62), 21.7% above the 52-week low ($464.52).

0. What this is answering

The recurring watchlist question is: "MA is Visa's payments-duopoly peer — should it fill the Evergreen Compounders vacancy, and is it a better home for new capital than the Visa position the agency already holds (currently TRIM, conviction 7.0, re-analyzed 2026-08-27)?" The 2026-08-27 Visa re-analysis addressed a narrower version of this ("is MA a cheaper way to own the same economics") and found no clean rotation on a same-basis comparison at that time (MA P/E 32.53x vs V 32.31x, MA PEG 1.83-1.84 vs V 1.74). This report is the first full standalone analysis of MA itself, re-runs that comparison fresh (same day, same vendor, same fields for both names), and answers the four questions the mandate poses in §5.

1. General Health (Fundamentals)

Free cash flow — the backbone

2022 2023 2024 2025 TTM
FCF $10.10B $10.89B $13.59B $16.43B $16.96B
YoY growth — +7.8% +24.8% +20.9% +3.2% vs FY25
FCF/share — — — $18.14 ~$19.2-19.5

3yr FCF CAGR: 17.6%. More importantly, the TTM figure is above the FY2025 annual figure — FCF/share is still compounding on the trailing-twelve-month view, not stalling. This is a meaningful point of difference from Visa, whose 2026-08-27 re-analysis found TTM FCF/share had plateaued ($9.80 vs FY2025's $9.83) for the first time in its uptrend. MA shows no equivalent stall.

Capital allocation (FY2025, $16.43B FCF)

Use $ % of FCF
Buybacks $11.73B 71.4%
Dividends $2.76B 16.8%
Total shareholder return $14.49B 88.2%
Acquisitions $0 (2024: $2.51B) —
Net debt issuance +$0.49B —

No debt-funded buyback this cycle (contrast Visa's TTM capital return running at 125% of FCF, partly funded by a $3.0B debt issuance landing in its softest FCF quarter). MA's return of capital is disciplined and fully self-funded, leaving genuine headroom.

Debt-to-Assets & leverage

Debt/Assets 35.1% (2025) — moderate, but higher than Visa's ~25%. Net debt (total debt $24.64B − cash $11.61B) ÷ EBITDA (~$22.2B TTM) ≈ 0.59x — low-risk for an investment-grade issuer with 55%+ ROIC, but visibly more levered than Visa's ~0.32x. This is a genuine, if minor, point in Visa's favor on balance-sheet conservatism.

Shares outstanding

Diluted shares: 971M (2022) → 906M (2025), -2.3%/yr CAGR (3yr) — steady buyback-driven reduction, comparable in pace to Visa's.

Top & bottom line growth

2022 2023 2024 2025
Revenue $22.24B $25.10B (+12.9%) $28.17B (+12.2%) $32.79B (+16.4%)
Net income $9.93B $11.20B (+12.8%) $12.87B (+14.9%) $14.97B (+16.3%)
Diluted EPS $10.22 $11.83 (+15.8%) $13.89 (+17.4%) $16.52 (+18.9%)

3yr CAGRs: Revenue 13.8%, Net income 14.7%. Growth is accelerating into 2025, not decelerating, and EPS is outrunning net income on the steady buyback. TTM revenue growth 14.1% yoy; Q2 2026 printed ccy revenue +12% with the FY26 guide raised to the high end of low-double-digit growth on a strong H1 — this is a business getting faster, not slower.

Per-share view

Revenue/share $36.19 (FY2025 annual), FCF/share $18.14 (FY2025) → ~$19.2-19.5 TTM. Both rising faster than the buyback alone would produce, confirming organic per-share value creation, not just financial engineering.

§1 verdict: clears the health bar cleanly. Every checklist item — FCF trend, capital discipline, leverage, share count, top/bottom-line growth, per-share metrics — reads as strong or improving. No incomplete or contradictory data points found on the core financials.

2. Moat & Competitive Advantage

Quantitative base

ROIC (roic.ai, invested-capital basis): 54.4% (2024) → 57.6% (2025) — rising. Independently cross-checked by hand (NOPAT ÷ invested capital from fin.py's balance-sheet series): ~52.8% → ~58.4%, same direction, same order of magnitude. This is an exceptionally high and improving return on capital, consistent with an intact, strengthening moat.

Gross margin — a live instance of the Visa data trap. get_stock_info's grossMargins field reads 100% for MA (grossProfits field is set exactly equal to totalRevenue) — the same synthesized-gross-margin defect the 2026-08-27 Visa report found and filed for Visa. The real figure, from roic.ai's cost-of-revenue-based calculation: 77.9% (2025), up from 76.3% (2024) — still excellent and rising, just not "100%." Use operating margin (~59.5-61.1%, also expanding) as the reliable GAAP-derived line for this business type.

Revenue-stream map

  1. Domestic assessments / transaction processing — the core toll-booth, tied to gross dollar volume (+8% Q2'26). Mature, still growing with consumer spend.
  2. Cross-border volume fees — higher-margin, travel/e-commerce driven, +12% Q2'26.
  3. Value-added services & solutions (cyber & intelligence, data & services/consulting, marketing/loyalty) — now over 40% of net revenue and growing faster than the network (+18% Q2'26), built substantially through acquisition (NuData, RiskRecon, Ekata, Dynamic Yield, and now BVNK). This mirrors Visa's own VAS diversification strategy (+34% at Visa's last print) — both networks are executing the identical playbook of layering data/security/loyalty services on top of the raw network fee.

Adversarial stress-test — "how would a well-funded rival attack?"

  • Real-time / account-to-account rails (FedNow, RTP) — bank-owned, no interchange-fee model. Credible for bill-pay and high-value B2B; weak on consumer fraud liability-shift, dispute resolution, and rewards infrastructure the card rails provide. Limited near-term threat to everyday consumer spend.
  • Stablecoins / on-chain settlement — the most credible structural, multi-year threat. Lets counterparties settle directly, bypassing interchange. Both networks are pricing this in and moving to co-opt it (see below) rather than only defend against it.
  • Big Tech wallets (Apple Pay, Google Pay) — sit on top of card rails; reinforce rather than disintermediate MA/V, which still collect the network fee regardless of the front-end wallet.
  • Agentic commerce / AI-agent-initiated payments — genuinely new and unresolved. A cost-optimizing AI shopping agent could in principle route around interchange-bearing rails, but needs merchant acceptance and a trust/authentication/dispute-resolution layer that does not yet exist outside the card networks — which is precisely the gap MA and V are both racing to fill (see moat-defense below).
  • Closed-loop competitors (Amex, PayPal/Venmo balances) — smaller scale, do not threaten the open-loop duopoly structurally.

Moat-defense evaluation

Management is buying into the disruption vector rather than only defending against it: BVNK acquisition (up to $1.8B) for stablecoin infrastructure/settlement; Mastercard Move enabling near-real-time stablecoin payouts across 130 countries; "Agent Pay" and a "Know Your Agent (KYA)" identity/trust framework aimed at becoming the authentication layer for AI-agent commerce — racing Visa's parallel Trusted-Agent-Protocol/KYA push (both networks converging on the same defensive playbook within weeks of each other, per the 2026-09-10 news flow). This is a credible, well-funded, first-mover-adjacent posture — not proof of success, since none of these bets have disclosed volume yet, but the right posture for the risk.

Evergreen assessment

9/10 — same tier as Visa. Duopoly network economics are about as durable as exists in financial infrastructure; the disruption arc here is a 5-10 year question, not an immediate one, and management is spending to own the next settlement rail rather than merely defend the current one. This is not a case of one moat being clearly wider than the other — MA and V are, on the evidence gathered here, a genuine coin-flip on moat quality, differentiated mainly by price and recent momentum (§3-5), not by structural durability.

Regulatory overhang — MA vs V, explicitly

Visa Mastercard
DOJ debit-monopolization Active lawsuit, fact discovery closes 2026-10-16 Civil Investigative Demand (CID) on the U.S. debit program — an investigatory step, one rung below a filed suit
CCCA (multi-network debit routing mandate) Same exposure Same exposure — industry-wide, not V-specific
Interchange class settlement (~$38B) Named defendant Named defendant — same settlement, same terms

MA's regulatory posture is a half-step less acute than V's right now (investigation vs. litigation in active discovery), though a DOJ win against Visa would likely set a precedent that reaches Mastercard too. Not a reason to prefer MA outright, but a real, current difference worth naming.

A confirmed data-quality note: no dual-class trap here

Unlike Visa (Class A/B/C, pitfall-yahoo-share-count-dual-class-fpi), Mastercard has a single class of common stock. sharesOutstanding (869.46M) reconciles against marketCap ÷ price (495.27B ÷ 565.37 = 875.86M) to within 0.7% — normal timing noise, not the ~9.6% gap the dual-class defect produces. Ruled out explicitly so it isn't assumed by analogy to Visa.

3. Valuation

A live instance of pitfall-vendor-forward-eps-is-the-wrong-fiscal-year — new ticker for the note

Yahoo's forwardPE (24.56, implying forwardEps $23.02) is not MA's FY2026 consensus — it is FY2027, one fiscal year past the year currently underway (MA's FY2026, two quarters already reported: Q1 diluted EPS $4.35, Q2 $4.97). The correct current-year read is epsCurrentYear/priceEpsCurrentYear: EPS $19.93 → true current-year forward P/E 28.37x — a +20.6% implied full-year growth over FY2025's $16.52, consistent with the company's own guided low-double-to-mid-teens trajectory and the trailing EPS growth already running +19-22%. fin.py's printed PE(fwd) 24.56 inherits this defect and should not be quoted as MA's forward multiple. The PE(ttm) 31.25, tying exactly to trailingEps 18.09, needed no correction.

Fresh, same-day, same-vendor comparison against Visa (both pulled 2026-09-10)

Visa Mastercard
Price $367.21 $565.37
TTM P/E 31.25x 31.25x — identical
PEG (vendor field, both names) 1.66 1.48-1.51 — cheaper on growth-adjusted basis
True current-year fwd P/E (both affected by the wrong-FY pitfall) ~27.8x (Aug-27 EPS estimate carried forward — not refreshed today) 28.37x (fresh today)
Recent EPS growth (adjusted) ~+10-11% (Q3 FY26) +19-22% (Q2 2026)
Distance from own 52-week high -4.8% -6.0%
Debt/Assets ~25% 35.1%
Net debt/EBITDA ~0.32x ~0.59x

This is a genuinely new finding, and it moves the rotation question since the 2026-08-27 pass. At that time MA's TTM P/E (32.53x) was higher than V's (32.31x) and its PEG (1.83-1.84) was also higher — the basis for "no clean rotation." Today, on the identical methodology, the two trade at the exact same TTM P/E (31.25x), and MA's PEG is meaningfully lower because its trailing earnings growth is running roughly double Visa's. The multiple gap that used to favor Visa has closed; the growth-adjusted gap now favors MA. Caveat: Visa's current-year EPS estimate here is carried forward from the 2026-08-27 report, not refreshed today — a fully live comparison would re-pull V's fresh epsCurrentYear field. Flagging this rather than presenting it as more precise than it is.

Valuation models

Model Fair value Weight Basis
Graham IV $51.02 0% (inapplicable) Buyback-hollowed book (BVPS $6.40) — identical treatment to Visa's Graham disregard. Tangible book is actually negative (goodwill $9.56B alone exceeds total equity $7.74B), a byproduct of the buyback+M&A-funded VAS buildout, not distress.
Bogle Expected Return ~11-16%/yr (center ~13-14%) 20% 0.61% yield + 13-15% guided/trailing EPS growth ± minimal multiple change (TTM P/E sits mid-band, limited further re-rating room either way).
DYT $535-696 (center ~$600-615) 15% Current yield 0.61% sits above its 5yr average (0.55%) — a genuine "cheap" signal, not the price-driven-yield inversion trap, because the dividend has been raised steadily (+14.5-14.6%/yr, 5yr) while the price consolidated over the past year rather than falling. This is the opposite of what happened to Visa's DYT read (yield compressed below its average as price ran up on a flat dividend).
DDM (2-stage, flat 15% div growth × 10yr, then 5-5.5% terminal, 9.5-10% discount) ~$160-220 ~5% (not meaningfully weighted) Run with the same structure the March/August Visa reports used, and it lands dramatically below every other model. Flagged as a poor fit, not a finding: at a 0.61% payout yield, almost all of MA's shareholder return flows through buybacks and EPS growth, not the dividend — a strict DDM misses most of the return mechanism, the same reason Graham is excluded. Presenting the number for completeness, not treating it as informative.
P/FCF (primary) $521-618 (27-32x TTM FCF/share ~$19.3) 45% MA's own 2-year historical band (roic.ai, FY2024-25 year-round high/low/average): 24.6-34.8x, averaging 29.5-30.7x. A 27-32x "normal" band (trimming the tail extremes) applied to TTM FCF/share gives this range.

Composite fair value: $520-615 (center ~$565-570). Spot ($565.37) sits almost exactly at the center of this range — fairly valued, neither a bargain nor a stretch. This is the key contrast with Visa's 2026-08-27 finding, where spot sat ~10% above the top of its own composite range. MA is not on sale, but it is not overpriced either — a materially better setup than its watchlist-held peer.

Entry / Trim

  • Entry (full accumulate zone): $470-525 (26-29x TTM EPS $18.09) — the lower third of MA's own historical multiple band, last touched near the 52-week low ($464.52).
  • Current price ($565.37) is fair value, not a discount — defensible for a starter-size position in a name the portfolio does not currently hold at all, but not a "back up the truck" price. Build size on any pullback toward the entry zone above.
  • Trim 34x ttm (≈ $615 at TTM EPS $18.09) — set near the top of MA's own historical trailing-P/E band (year-end highs of 36.4x/38.6x over FY25/24, averages 33.7-34.1x). Written on the ttm basis deliberately, for the same reason as Visa's trim: forwardPE is confirmed on the wrong fiscal year for this name (see above), so fwd would inherit a systematically understated multiple and set the trim too low.

4. Sentiment & Intelligence

  • Sell-side: unanimous "Strong Buy" (1.375 mean, 37 analysts), target mean $670.92 (+18.6% upside from spot), range $550-740. 13 rating/price-target actions in the trailing ~6 months — every single one a raise, zero downgrades or cuts. Momentum in estimates is one-directional.
  • Insider activity: routine 10b5-1 sales tied to option exercises and RSU vesting across the CEO/CFO/officer bench (Miebach, Mehra, McLaughlin, Kirkpatrick, and others), essentially every month since early 2025. Zero open-market purchases in the reviewed window — the same neutral pattern found on Visa (typical for a well-compensated mega-cap bench, not a red flag on its own, but no golden-flag signal either).
  • Recent news flow (past 48-72hrs, per fin.py --news): CFO commentary citing "resilient spending" fueling growth in services, stablecoins, and a UAE cross-border deal; a Flowcart in-chat-payments partnership (agentic commerce); an "AI Checkout Pact" targeting fraud in agent-initiated purchases; and parallel coverage asking whether MA's digital-wallet push and Visa's rival KYA initiative can accelerate agentic-commerce adoption. Both networks are visibly racing the same emerging-rail land-grab in real time — informative in itself: this reads as an arms race between two well-funded incumbents, not a one-sided threat to either.
  • Macro read-through: the CFO's "resilient spending" framing is a data point for near-term consumer-volume trajectory at both card networks, not MA-specific.

5. Explicit answers to the mandate

(1) Does it clear the §1 health bar? Yes, cleanly. FCF 3yr CAGR 17.6% and still accelerating on a TTM basis (no plateau, unlike Visa's current stall); capital allocation disciplined and self-funded (88% of FCF returned, no debt-funded buyback); leverage modest (0.59x net debt/EBITDA); share count falling steadily (-2.3%/yr); revenue and earnings growth both accelerating into 2025-26. No incomplete or contradictory data found on the core financials.

(2) Is it in a buy zone now, or watch? A close call, honestly stated: fair value, not a discount. Composite FV $520-615 (center ~$565-570) sits almost exactly on top of spot ($565.37). Strict discipline says WATCH for the $470-525 entry zone before sizing up. But because this is a sleeve vacancy — the portfolio holds no direct exposure to this duopoly economics today — and because MA is priced fairly while its only tracked peer (V) is priced ~10% above its own band, a starter-size ACCUMULATE today is defensible; treat $470-525 as where a full-size position belongs. Trim 34x ttm (~$615).

(3) Does it beat the weakest current Evergreen members (PCTY/IBM, both HOLD 5.5) — and is it a better hold than V (TRIM 7.0)? Beats PCTY/IBM decisively, on every axis. ROIC 57-58% and rising vs. IBM's ~10.5% and falling; FCF still compounding vs. IBM's flat H1 resting on an inventory buy-ahead; dividend growth 14.5-14.6%/yr vs. IBM's ~0.6%/yr (a dead Aristocrat streak); share count falling -2.3%/yr vs. IBM's rising +1.1%/yr. Against PCTY: MA's growth is accelerating where PCTY's is decelerating (FY27 guide cut to ~7%), and MA's moat (payments duopoly) is structurally wider than PCTY's single-market payroll niche now under direct Rippling/Dayforce/UKG pressure.

Against Visa: not a clean "sell V, buy MA" rotation, but the relative-value case has moved in MA's favor since 2026-08-27. Both names now trade at the identical TTM P/E (31.25x), but MA's PEG is lower (~1.48-1.51 vs. 1.66) because its trailing earnings growth is running roughly double Visa's, and MA sits at fair value while Visa sits ~10% above its own band. Visa remains the wider network by cross-border volume and the more conservative balance sheet, and nothing here argues for exiting the Visa position — its own TRIM verdict is a sizing discipline call at an elevated price, not a thesis break. For new capital being deployed into duopoly payments exposure today, Mastercard is the better marginal dollar.

(4) Proposed sleeve + conviction 🏛 Evergreen Compounders. Conviction 7.5. Above both PCTY/IBM (5.5) and above Visa's current TRIM conviction (7.0) — reflecting the same duopoly moat quality as Visa, priced fairly rather than above its own band, with faster trailing earnings momentum and a credible (if unproven) proactive stance on the stablecoin/agentic-commerce disruption vectors. Held below 8.0 because of the DOJ CID overhang, the higher leverage than Visa, and because "fair value" is not "cheap" — there is no absolute margin of safety at 31.25x TTM earnings, only a relative one against the tracked peer.

6. What this pass did NOT test

  • MA's own multiple band is built from only 2 fiscal years (FY2024-25) — roic.ai's coverage for this ticker did not extend further back on this pass. A 5-8yr band (matching the framework's preferred CAGR window) would sharpen the P/FCF and P/E fair-value ranges; treat the current bands as directionally right but not deeply verified.
  • Visa's side of the fresh comparison in §3 uses a current-year EPS estimate carried forward from the 2026-08-27 report, not re-pulled today. A fully live rotation call would refresh epsCurrentYear/priceEpsCurrentYear for V same-day.
  • The BVNK acquisition and Agent Pay/KYA initiatives have no disclosed volume or revenue contribution yet — graded on management's posture and capital commitment, not on results.
  • Segment-level VAS detail (the specific cyber/data/consulting sub-mix) was not rebuilt from the 10-K — only the headline VAS growth rate from the Q2 2026 print was used.
  • This is a first-ever file on MA — no prior baseline exists to differentiate carried vs. drifted claims; treat this whole report as the new baseline for any future /analyze-from-before MA.

Sources